Invention Grant
US07947743B2 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
有权
在获得用于治疗双相情感障碍的药物中使用阿格美林
- Patent Title: Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
- Patent Title (中): 在获得用于治疗双相情感障碍的药物中使用阿格美林
-
Application No.: US11142612Application Date: 2005-06-01
-
Publication No.: US07947743B2Publication Date: 2011-05-24
- Inventor: Christian De Bodinat , Elisabeth Mocaer
- Applicant: Christian De Bodinat , Elisabeth Mocaer
- Applicant Address: FR Suresnes Cedex
- Assignee: Les Laboratories Servier
- Current Assignee: Les Laboratories Servier
- Current Assignee Address: FR Suresnes Cedex
- Agency: Hueschen and Sage
- Priority: FR0503937 20050420
- Main IPC: A61K33/00
- IPC: A61K33/00 ; A61K31/19 ; A61K31/165 ; A61P25/24
Abstract:
The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, on its own or in association, in obtaining medicaments intended for the treatment of bipolar disorders, especially bipolar disorders of types I and II, and more especially bipolar disorders of type I.
Public/Granted literature
- US20060240127A1 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders Public/Granted day:2006-10-26
Information query
